Total Payments
$6,245
2024 Payments
$972.88
Companies
49
Transactions
319
Medicare Patients
12,494
Medicare Billing
$652,870
Payment Breakdown by Category
Food & Beverage$6,165 (98.7%)
Education$80.81 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,165 | 315 | 98.7% |
| Education | $80.81 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $984.08 | 61 | $0 (2024) |
| Janssen Biotech, Inc. | $680.59 | 41 | $0 (2024) |
| NeoTract Inc. | $434.33 | 8 | $0 (2020) |
| Teleflex LLC | $407.14 | 3 | $0 (2023) |
| UROGEN PHARMA, INC. | $392.00 | 17 | $0 (2024) |
| ABBVIE INC. | $376.72 | 23 | $0 (2024) |
| PFIZER INC. | $318.80 | 25 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $311.65 | 15 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $266.86 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $216.00 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.88 | 51 | ABBVIE INC. ($174.58) |
| 2023 | $1,212 | 55 | Astellas Pharma US Inc ($198.38) |
| 2022 | $761.32 | 48 | PFIZER INC. ($123.98) |
| 2021 | $845.44 | 52 | Astellas Pharma US Inc ($307.80) |
| 2020 | $555.91 | 21 | Astellas Pharma US Inc ($200.73) |
| 2019 | $489.86 | 34 | Janssen Biotech, Inc. ($128.68) |
| 2018 | $846.88 | 36 | Janssen Biotech, Inc. ($198.51) |
| 2017 | $560.75 | 22 | NeoTract Inc. ($225.41) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: HORMONE THERAPY | ||||||
| 11/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Immunotherapy | ||||||
| 10/03/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Immunotherapy | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: HORMONE THERAPY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Oncology | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: HORMONE THERAPY | ||||||
| 08/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: HORMONE THERAPY | ||||||
| 07/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Prostate cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,970 | 4,880 | $640,448 | $145,330 |
| 2022 | 40 | 2,920 | 6,049 | $864,726 | $166,406 |
| 2021 | 38 | 3,246 | 6,332 | $614,051 | $155,552 |
| 2020 | 43 | 3,358 | 8,007 | $710,073 | $185,582 |
Total Patients
12,494
Total Services
25,268
Medicare Billing
$652,870
Procedure Codes
158
All Medicare Procedures & Services
158 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 624 | 797 | $198,012 | $66,771 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $44,003 | $12,721 | 28.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 257 | $52,942 | $11,663 | 22.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 278 | 348 | $24,708 | $6,271 | 25.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 76 | 84 | $52,608 | $4,785 | 9.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 35 | $11,042 | $4,454 | 40.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 324 | 426 | $13,620 | $3,578 | 26.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 31 | 36 | $45,781 | $3,445 | 7.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 34 | 34 | $18,216 | $3,080 | 16.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $9,213 | $2,876 | 31.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 21 | 22 | $38,742 | $2,544 | 6.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 601 | 746 | $18,486 | $2,541 | 13.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 12 | 12 | $9,912 | $2,218 | 22.4% |
| 86316 | Analysis for detection of tumor marker | Office | 2023 | 80 | 89 | $4,539 | $1,815 | 40.0% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 14 | 16 | $6,867 | $1,763 | 25.7% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 81 | 90 | $7,650 | $1,622 | 21.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 19 | 20 | $8,131 | $1,514 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,696 | $1,503 | 32.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 59 | 59 | $18,399 | $1,416 | 7.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 25 | 26 | $9,126 | $1,361 | 14.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 31 | 44 | $4,444 | $1,113 | 25.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 27 | $3,018 | $1,060 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,632 | $849.18 | 23.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 100 | 117 | $10,986 | $837.90 | 7.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $1,639 | $685.52 | 41.8% |
About Dr. Patrick Wirtz, M.D
Dr. Patrick Wirtz, M.D is a Urology healthcare provider based in Blue Ash, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881851467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Wirtz, M.D has received a total of $6,245 in payments from pharmaceutical and medical device companies, with $972.88 received in 2024. These payments were reported across 319 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($6,165).
As a Medicare-enrolled provider, Wirtz has provided services to 12,494 Medicare beneficiaries, totaling 25,268 services with total Medicare billing of $652,870. Data is available for 4 years (2020–2023), covering 158 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Blue Ash, OH
- Active Since 05/21/2008
- Last Updated 12/02/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1881851467
Products in Payments
- MYRBETRIQ (Drug) $527.35
- JELMYTO (Drug) $392.00
- XTANDI (Drug) $389.68
- ERLEADA (Drug) $353.40
- PROVENGE (Drug) $340.48
- Erleada (Drug) $325.81
- BOTOX (Biological) $270.50
- UROLIFT (Device) $268.30
- ORGOVYX (Drug) $265.30
- Urolift - UL400 (Device) $225.41
- Myrbetriq (Drug) $218.47
- UroLift (Device) $208.92
- KEYTRUDA (Biological) $178.12
- Nubeqa (Drug) $140.36
- Axonics r-SNM System (Device) $139.37
- UroLift System (Device) $138.84
- SpeediCath (Device) $131.10
- COOK MEDICAL EXTRACTORS (Device) $128.22
- TECENTRIQ (Biological) $106.88
- Axumin (Drug) $93.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Blue Ash
Mark Delworth, Md, MD
Urology — Payments: $181,185
Urology $181,185
Gary Kirsh, Md, MD
Urology — Payments: $180,723
Urology $180,723
Dr. Katherine Voss, M.d, M.D
Urology — Payments: $6,829
Urology $6,829
Ben Niver, M.d, M.D
Urology — Payments: $6,002
Urology $6,002
Chandrasekar Dheenan, Md, MD
Urology — Payments: $4,193
Urology $4,193
Jeffrey Zipkin, Md, MD
Urology — Payments: $2,838
Urology $2,838